Skip to main content

Snapchat wants to help you bust coronavirus myths with a new game

A new Snapchat filter wants to stop the spread of coronavirus misinformation by turning busting myths into a trivia game. 

The COVID-19 Myth Busting game rolled out on Thursday, March 26, and is an interactive filter that prompts players to choose between fact or fiction when it comes to the coronavirus, according to Mashable. You can then take a selfie and share your results with your friends, inviting them to play along with you for the 10-question game. 

Players will be prompted with statements about the coronavirus and have to choose if it is a fact or a myth. You can expect questions like “Thermal scanners can detect that someone is infected with COVID—19” (hint, it’s false), and “Spraying chlorine all over your body will not kill COVID-19” (which is obviously true). 


The filter game is a form of entertainment in these dull, social distancing times, while also providing useful information about the coronavirus outbreak. All of the information from the game comes from the World Health Organization (WHO), so you know you’re getting the facts. 

There has been a lot of misinformation and conspiracy theories about coronavirus spreading around the internet, like the rumor that 5G network speeds caused the outbreak (completely false).

The new filter is Snapchat’s unique way of providing credible coronavirus facts to its users. Other platforms have also added their own version of a coronavirus information hub, including Facebook, which started to put credible coronavirus information at the top of its news feed. Here, you’ll find articles, videos, advice, and posts containing accurate and helpful information about the coronavirus outbreak. 

Google Maps is also helping spread awareness, especially when it comes to what you should do if you have any coronavirus symptoms. Now, when people search for a doctor’s office or other medical facilities on Google Maps, they are prompted with a warning about how they should call their doctor before going anywhere in-person to help stop the rapid spread of the virus. 

As of Thursday, there have been more than 495,080 confirmed cases of the coronavirus worldwide, and 22,295 confirmed deaths, according to an online dashboard that tracks cases.

Editors' Recommendations

Allison Matyus
Former Digital Trends Contributor
Allison Matyus is a general news reporter at Digital Trends. She covers any and all tech news, including issues around social…
How to sign up for a coronavirus vaccine trial
Cambridge Biotech Moderna Leads in Race For Coronavirus Vaccine

With the race to develop a coronavirus vaccine heating up, clinical studies around the U.S are looking for willing participants to help them complete various stages of their research. Tech conglomerates Moderna, AstraZeneca, Johnson & Johnson, and Novavax are all in various stages of human trials, each of which requires hundreds of volunteers. So how does one sign up for a vaccine trial?
How to sign up for a coronavirus trial
While the words "scientific trial" may bring up images of mad scientists, the average clinical study is an important part of the vaccine development process. After methods prove hopeful in laboratories, researchers then perform several detailed studies with humans, to perfect the product. To speed up trial involvement for a coronavirus vaccine, the U.S. National Institute of Health has launched an online public network that connects possible volunteers with hundreds of research facilities across the U.S.

But a lot still has to happen before scientists can stick you with a needle. Possible volunteers must be 18 years or older, and must fill out a volunteer screening history. Signing up for the database takes less than 10 minutes, and will automatically connect users with the trial closest to them.

Read more
Fauci ‘cautiously optimistic’ we will have a coronavirus vaccine this year
gloved hands holding coronavirus test tube stylized image

Dr. Anthony Fauci told a House panel he is "cautiously optimistic" that a coronavirus vaccine will be developed this year.

“We hope that as the time we get into the late fall and early winter we will have, in fact, a vaccine that we can say would be safe and effective,” Fauci, the Director of the National Institute of Allergy and Infectious Diseases, testified before a Democrat led-panel on the outbreak on Friday, July 31. “One can never guarantee the safety or effectiveness unless you do the trial, but we are cautiously optimistic.”

Read more
New coronavirus vaccine triggers immune response in early testing
medical employee holding mask stylized image

A coronavirus vaccine developed by Oxford University and drug company AstraZeneca triggered an immune response in early trials, according to a study published on Monday, July 20. 

The vaccine produced strong immune responses in patients inoculated with both single- and two-dose versions of the vaccine. The promising results were first published in the scientific journal The Lancet.

Read more